Thinking Outside The Cube
Welcome to the Genomadix™ Blog!
We provide regular updates on the power of molecular testing and the various industries in which it can be applied. We also tell customer and employee stories and share related studies and guidelines that impact the various industries we support.
META JACC Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy
META JACC Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy Please download the file to learn
META LANCET Guided versus standard antiplatelet therapy in patients undergoing
META LANCET Guided versus standard antiplatelet therapy in patients undergoing Please download the file to learn more.
Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles
Please view the file to learn more.
Increased frequency of CYP2C19 loss‐of‐function alleles in clopidogrel‐treated patients with recurrent cerebral ischamia
Please view the file to learn more.
Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke
Please view the file to learn more.
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack.pdf
Please view the file to learn more.
Clin Pharma and Therapeutics – 2022 – Lee – Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19
Please view the file to learn more.
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
Please view the file to learn more.
Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications
Please view the file to learn more.
